Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV, Combination Therapy”

853 trials

Showing 20 of 853 results

Not applicableStudy completedNCT00099684
What this trial is testing

Safety, Effectiveness, and Tolerability of Ezetimibe Combined With Statins for the Treatment of High Cholesterol in HIV Infected Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 44
Early research (Phase 1)Study completedNCT00002321
What this trial is testing

A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
Chiron Corporation
Testing effectiveness (Phase 2)Study completedNCT00002235
What this trial is testing

A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 6
Testing effectiveness (Phase 2)Study completedNCT00000626
What this trial is testing

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Who this might be right for
HIV InfectionsHodgkin's Disease
National Institute of Allergy and Infectious Diseases (NIAID) 27
Large-scale testing (Phase 3)Study completedNCT00002140
What this trial is testing

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

Who this might be right for
Mycobacterium Avium-intracellulare InfectionHIV Infections
Pfizer
Not applicableStudy completedNCT00000950
What this trial is testing

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 50
Testing effectiveness (Phase 2)Ended earlyNCT02239835
What this trial is testing

Tipranavir and Ritonavir vs. Saquinavir and Ritonavir Used With Two Nucleoside Reverse Transcriptase Inhibitors in Single Protease Inhibitor-experienced HIV-1 Patients

Who this might be right for
HIV Infections
Boehringer Ingelheim 79
Testing effectiveness (Phase 2)Study completedNCT01160120
What this trial is testing

Therapeutic Drug Monitoring (TDM) in Generic Tenofovir/Lamivudine/Efavirenz

Who this might be right for
HIV
The HIV Netherlands Australia Thailand Research Collaboration 100
Testing effectiveness (Phase 2)Study completedNCT00002171
What this trial is testing

Viracept in HIV-Positive Women

Who this might be right for
HIV Infections
Agouron Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Testing effectiveness (Phase 2)Study completedNCT02175680
What this trial is testing

Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection

Who this might be right for
HIVHuman Immunodeficiency Virus
CytoDyn, Inc. 43
Testing effectiveness (Phase 2)Study completedNCT00052117
What this trial is testing

Four-Drug Combination Treatment in Hiv-Infected Subjects Failing Therapy With Antiretroviral Regimens

Who this might be right for
HIV Infections
Pfizer 300
Post-approval studies (Phase 4)Ended earlyNCT02322099
What this trial is testing

Alendronate for Prevention of AntiRetroviral Therapy-associated Bone Loss

Who this might be right for
Bone Demineralization
University College Dublin 53
Not applicableStudy completedNCT00000923
What this trial is testing

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 110
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Not applicableStudy completedNCT00000844
What this trial is testing

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 560
Large-scale testing (Phase 3)Looking for participantsNCT07682961
What this trial is testing

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

Who this might be right for
HIV Infections
Gilead Sciences 590
Early research (Phase 1)Study completedNCT00038480
What this trial is testing

Safety and Effectiveness of Lopinavir/Ritonavir in HIV Infected Infants

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 31
Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Not applicableStudy completedNCT00006444
What this trial is testing

The Effects of Combination Anti-HIV Medication on Human Papillomavirus (HPV) in HIV-Infected Women

Who this might be right for
HIV InfectionsPapilloma
National Institute of Allergy and Infectious Diseases (NIAID) 160
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation